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Tecoma stans (yellow elder) has shown medicinal properties and antimicrobial activity.
Previous reports on antifungal activity of T. stans preparations and presence of trypsin
inhibitor activity from T. stans leaves stimulated the investigation reported here. In
this work, we proceeded to the purification and characterization of a trypsin inhibitor
(TesTI), which was investigated for anti-Candida activity. Finally, in order to determine
the potential of TesTI as a new natural chemotherapeutic product, its cytotoxicity to
human peripheral blood mononuclear cells (PBMCs) was evaluated. TesTI was isolated
from saline extract by ammonium sulfate fractionation followed by ion exchange and gel
filtration chromatographies. Antifungal activity was evaluated by determining the minimal
inhibitory (MIC) and fungicide (MFC) concentrations using fungal cultures containing
only yeast form or both yeast and hyphal forms. Candida cells treated with TesTI
were evaluated for intracellular ATP levels and lipid peroxidation. Cytotoxicity of TesTI
to PBMCs was evaluated by MTT assay. TesTI (39.8 kDa, pI 3.41, K i 43 nM) inhibited
similarly the growth of both C. albicans and C. krusei culture types at MIC of 100 µg/mL.
The MFCs were 200 µg/mL for C. albicans and C. krusei. Time-response curves
revealed that TesTI (at MIC) was more effective at inhibiting the replication of C. albicans
cells. At MIC, TesTI promoted reduction of ATP levels and lipid peroxidation in the
Candida cells, being not cytotoxic to PBMCs. In conclusion, TesTI is an antifungal agent
against C. albicans and C. krusei, without toxicity to human cells.
Keywords: protease inhibitor, antifungal activity, Candida, oxidative stress, anionic protein
INTRODUCTION
The chemical protection of plants comprises several compounds, including different classes of
defense proteins (Carlini and Grossi-de-Sá, 2002; Dang and Van Damme, 2015). The insecticidal
and antimicrobial effects of these proteins against pathogens and predators have drawn the
attention of researchers for their potential biotechnological applications (Paiva et al., 2013a,b).
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Protease inhibitors are compounds that block or reduce
the activity of proteolytic enzymes, acting in regulation
of endogenous proteolytic activity. The participation of
proteinaceous protease inhibitors in the defense mechanisms of
plants and animals has been reported (Habib and Fazili, 2007;
Zhu-Salzman and Zeng, 2015) and, in this sense, these molecules
have been evaluated for insecticidal and antimicrobial properties
(Fear et al., 2007; Kim et al., 2009; Soares et al., 2011; Paiva
et al., 2013a,b). Their antimicrobial activity can be attributed to
the ability to inhibit extracellular and/or intracellular proteases
(Paiva et al., 2013a). In addition, protease inhibitors can also
promote damage of cell membrane/wall, alteration of cell
permeability, inhibition of transcription and/or translation, and
induction of reactive oxygen species (ROS) production (Paiva
et al., 2013a; Macedo et al., 2016; Majchrzak-Gorecka et al.,
2016).
Tecoma stans (L.) Kunth (Bignoniaceae), also known as
yellow elder, is a plant native to the North and Central
Americas, which was introduced in Brazil for ornamental
purposes and became abundant due to the ease of seed
dispersion, rapid growth, and relative absence of natural enemies
(Passini and Kranz, 1997; Silva et al., 2008). T. stans leaves
are often used in the treatment of diabetes and have been
used in the synthesis of nanoparticles (Arunkumar et al.,
2013; Cruz and Andrade-Cetto, 2015). Extracts and compounds
(tannins, flavonoids, alkaloids, quinones, and saponins) from
this plant have shown antibacterial, antifungal, antitumoral, and
hypoglycemic activities (Binutu and Lajubutu, 1994; Aguilar-
Santamaría et al., 2009; Ramesh et al., 2009; Kameshwaran et al.,
2012). For example, an ethanolic extract from T. stans leaves
showed inhibitory and fungicidal effect on Candida tropicalis
and C. albicans (Al-Judaibi and Al-Yousef, 2014). Additionally,
T. stans is considered a plant resistant to pests and pathogens
(Gilman and Watson, 1994) and thus is attractive for research
purposes involving defense proteins.
Our laboratory works on the detection and isolation of
bioactive proteins from plants, mainly focused on lectins and
protease inhibitors. Since no information was found in the
literature about the presence of these proteins in T. stans, we
conducted a preliminary study that indicated that leaves of this
plant contain trypsin inhibitor activity while lectins were not
detected (Patriota et al., 2014). In this sense, the investigation
reported here was stimulated by the presence of trypsin inhibitor
in T. stans leaves together with the previous reports on antifungal
activity of T. stans preparations. In the present work, we report
the purification and characterization of a trypsin inhibitor from
T. stans leaves (TesTI) and its investigation for antifungal activity
against Candida species.
The yeasts from the Candida genus (Class Saccharomycetes,
Order Saccharomycetales) are opportunistic and pathogenic
fungi that cause cutaneous and mucosal infections; they also
cause systemic infections, mainly in immunocompromised
patients (Lima et al., 2008; Papon et al., 2013). There is an increase
in reports on the emergence of Candida resistant strains, which
may emerge even still during the course of medical treatment
(Arendrup, 2013). In this sense, the search for natural compounds
with anti-Candida activity has been stimulated (Rybalchenko
et al., 2010; Kim et al., 2012; Zhang et al., 2014; Yessoufou
et al., 2015). Antimicrobial peptides from animals and plants have
shown anti-Candida activity (Aerts et al., 2011; Cho and Lee,
2011) and the inhibition of proteases secreted by Candida species
is considered as an interesting antifungal strategy (Stewart and
Abad-Zapatero, 2001). Recently, Macedo et al. (2016) reported
that a trypsin inhibitor from Inga laurina seeds was able to inhibit
the growth of C. tropicalis and C. buinensis.
Finally, since compounds with high toxicity against human
cells cannot be considered potential chemotherapeutic products,
we determined the cytotoxicity of TesTI to human peripheral
blood mononuclear cells (PBMCs).
MATERIALS AND METHODS
Protein Extraction
Leaves were collected in the campus of the Universidade Federal
de Pernambuco (UFPE), with authorization (number 36301) of
the Instituto Chico Mendes de Conservação da Biodiversidade
(ICMBio). The leaves were dried at 28◦C for 7 days and powdered
using a blender. The leaf powder was then homogenized (16 h,
28◦C) at 10% (w/v) in 0.15 M NaCl using a magnetic stirrer.
The homogenate was filtered using a filter paper and the filtrate
was used as the extract. Protein concentration was measured
according to the method described by Lowry et al. (1951) using
a standard curve of bovine serum albumin (31.25–500 µg/mL).
Trypsin Inhibitor Activity
Assays for determination of trypsin inhibitor activity were
performed in 96-well microplates according to the protocol
described by Pontual et al. (2014). Bovine trypsin (5 µL;
0.1 mg/mL) in 0.1 M Tris-HCl pH 8.0 (Tris buffer) was incubated
with 30 µL of the leaf extract for 15 min at 28◦C. Then, 5 µL of
8 mM N-benzoyl-DL-arginyl-p-nitroanilide (BApNA) was added.
The volume of each well was adjusted to 200 µL with Tris
buffer. Trypsin activity in the absence of extract was considered
as 100% substrate hydrolysis. Blanks were performed submitting
the extract to the same reaction steps in the absence of substrate
and enzyme. Also, blanks of the substrate in the absence of
enzyme and sample were prepared. One unit of trypsin activity
was defined as the amount of enzyme that hydrolyzes 1 µmol
of BApNA per minute. Each milli-unit (mU) of trypsin activity
inhibited by the presence of extract corresponded to one unit of
trypsin inhibitor activity. Specific trypsin inhibitor activity was
calculated as the ratio of trypsin inhibitor activity (U) to the
amount of protein (mg) in the sample.
Isolation and Characterization of T. stans
Trypsin Inhibitor (TesTI)
The leaf extract was treated with ammonium sulfate at 80%
saturation (Green and Hughes, 1955) using magnetic stirring
for 4 h at 28◦C. After centrifugation (3,000 × g; 15 min) the
precipitate and supernatant fractions were collected and dialyzed
against distilled water (2 h) and Tris buffer (2 h). The precipitate
fraction (2 mL; 3.6 mg of protein) was loaded onto a DEAE-
cellulose (Sigma–Aldrich, USA) column (7.5 cm × 1.5 cm)
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equilibrated with Tris buffer (20 ml/h). After washing, the
adsorbed proteins were eluted with 1.0 M NaCl prepared in
the equilibration buffer. Fractions of 2.0 mL were collected and
dialyzed against 0.15 M NaCl (1 L; 4 h).
The PII pool (eluted from DEAE-cellulose chromatography)
was loaded (2 mL; 0.274 mg protein) onto a gel filtration
HiPrep 16/60 Sephacryl S-100 HR column coupled to the
ÄKTAprime plus system (GE Healthcare Life Sciences, Sweden).
Chromatography was performed using 0.15 M NaCl at a flow
rate of 0.5 mL/min. The fractions (2 mL) collected were pooled
into three groups (PIIa, PIIb, and PIIc) based on the absorbance
at 280 nm. The range of molecular mass of the components
in each pool was estimated by comparison with the migration
times of protein molecular weight markers (14.4–97 kDa)
chromatographed under the same conditions.
PIIa was then dialyzed against Tris buffer (1 L; 2 h) and loaded
(2 mL; 0.134 mg protein) onto a DEAE FF 16/10 column (GE
Healthcare Life Sciences, Sweden) coupled to the ÄKTAprime
system and previously equilibrated with Tris buffer (5.0 mL/min).
The adsorbed proteins were eluted using a gradient of 1.0 M
NaCl (0–100%) in Tris buffer. TesTI was enriched in the pool
of fractions eluted with 50–64% NaCl. The purification was
monitored by measuring the protein concentration and trypsin
inhibitor activity of all fractions.
TesTI (150 µg) was resuspended in rehydration buffer [8.0 M
urea, 2% (w/v) CHAPS, 1% (v/v) IPG buffer pH 3–10 and 0.002%
(w/v) bromophenol blue] and absorbed by the strip (7 cm; linear
pH gradient 3–10) passively for 16 h at 25◦C. The rehydrated strip
was submitted to isoelectric focusing using the Ettan IPGPhor
III system (GE Healthcare Life Sciences, Sweden) according to
the manufacturer’s instructions. The strip was then washed three
times with an equilibrating solution [50 mM Tris-HCl pH 8.8,
6.0 M urea, 30% (v/v) glycerol, 2% (w/v) SDS and 0.002% (w/v)
bromophenol blue] and transferred to the top of a 12% (w/v)
polyacrylamide gel containing SDS (Laemmli, 1970). Molecular
mass standards (12–225 kDa, GE Healthcare Life Sciences) were
also subject to electrophoresis. The polypeptides were stained
with 0.02% (w/v) Coomassie Blue G. The gel was analyzed using
the Image Master (GE Healthcare) software.
The Dixon plot analysis was used to determine the inhibitory
constant (K i) of TesTI for bovine trypsin (Segel, 1975).
Trypsin inhibition assay was carried out using two BApNA
concentrations (4 and 8 mM). TesTI solutions prepared at
concentrations ranging from 0.56 to 1.88 µM.
Antifungal Assay
Stored cultures of C. albicans (URM 5901), C. tropicalis (URM
6551), and C. krusei (URM 6391) were obtained from the Culture
Collections of the University Recife Mycologia, Departamento
de Micologia (UFPE). The fungal cultures were reactivated in
Sabouraud-Dextrose for 48 h at 30◦C (to obtain a yeast culture)
or 37◦C (to obtain a culture containing yeast and hyphal forms)
on a shaker. The culture concentration was adjusted to 3 × 106
colony-forming units (CFU) per mL for use in the assays.
Minimal inhibitory concentrations (MIC) of leaf extract,
precipitate fraction and TesTI were determined using 96-well
microtiter plates and both culture types. Each row of the plate
corresponded to an antifungal assay. First, 100 µL of Sabouraud-
Dextrose was added to each well, followed by the sample (100µL)
which was added to the third well and serially diluted (twofold
dilution) until the last well of the row. All the wells except
the first were inoculated with 20 µL of the fungal culture. The
first well corresponded to the negative control (contained only
culture medium) and the second well corresponded to the 100%
growth control (containing a 1:1 dilution of culture medium in
water). The plate was read at time zero and after 24 h using a
microplate reader at 600 nm (OD600). In this time interval, the
plate was incubated at 30◦C (assays using yeast cultures) or 37◦C
(assays using yeast/hyphae cultures). Each assay was performed
in triplicate and two independent experiments were performed.
The MIC was defined as the lowest sample concentration that
could reduce the OD600 by 50% or higher than that of 100%
growth control (Amsterdam, 1996). The minimal fungicide
concentrations (MFCs) were determined using the MIC assays as
reference. Aliquots of the wells corresponding to concentrations
≥MIC and 100% growth control were transferred to petri plates
containing Sabouraud-Dextrose-Agar and incubated for 24 h at
30 or 37◦C. MFC was defined as the concentration that reduced
the number of CFU by least 99.9% in comparison to the initial
inoculum.
Growth Curves of C. albicans and
C. krusei
Growth curves for C. albicans and C. krusei were established in
the absence and presence of TesTI. The assay was performed
in 96-well microplates using three wells of each row: the first
well corresponded to the negative control and the second well
corresponded to the 100% growth control, both prepared as
described above; the third well corresponded to the treatment
with TesTI at MIC. The microplate was incubated at 37◦C and
the optical density at 600 nm was determined every hour until
24 h. Two experiments were performed in duplicate.
ATP Quantification Assay
The quantification of intracellular ATP was performed using
the CellTiter-Glo Luminescent Cell Viability Assay kit (Promega
Corporation, USA), which is based on the reaction between
the luciferase from Photuris pennsylvanica (LucPpe2) and ATP
molecules generating a luminescent signal. C. albicans and
C. krusei cells (106 CFU) were treated for 24 h at 37◦C with
TesTI at MFC, MIC, 1/2 MIC, and 1/4 MIC. A 100% growth
control (non-treated cells) was also performed as described in
Section “Antifungal Assay.” After this period, the microplate
was maintained for 30 min at 25◦C and then the cells were
transferred to wells of an opaque-walled 96-well plate (100 µL
per well). Next, 100 µL of Cell Titer-Glo R© reagent was added
to each well and the contents were mixed for 2 min on an
orbital shaker to induce cell lysis. The plate was incubated
for 10 min at 25◦C and then the luminescence was recorded.
Three independent experiments were performed in triplicate.
The results were expressed as relative ATP levels, which were
calculated by the ratio between the level in the test assay and that
in the control assay.
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FIGURE 1 | Purification of trypsin inhibitor from Tecoma stans leaves
(TesTI). (A) Chromatography of precipitate fraction (obtained after treatment
of leaf extract with ammonium sulfate) on a DEAE-cellulose column. Washing
was performed using 0.1 M Tris-HCl pH 8.0. The arrow indicates the time of
addition of the eluent (1.0 M NaCl). PI: fractions 11–13; PII: 15–27; PIII: 32–33.
(Continued)
FIGURE 1 | Continued
(B) Gel filtration chromatography of PII (from DEAE-cellulose column) on
HiPrep 16/60 Sephacryl S-100HR column coupled to the ÄKTAprime plus
chromatography system. Three pools were separated: PIIa (fractions 22–27),
PIIb (28–47) and PIIc (48–58). (C) Chromatography of PIIa in the ion exchange
DEAE FF 16/10 column coupled to the ÄKTAprime plus system and
equilibrated with 0.1 M Tris-HCl pH 8.0. The elution step was performed using
a 1.0 M NaCl gradient (0–100%). TesTI corresponded to the pool of fractions
26–33, eluted with 50–64% of 1.0 M NaCl. Chromatographies were
monitored by measuring the absorbance at 280 nm.
Lipid Peroxidation Assay
The assay was performed using the Lipid Peroxidation (MDA)
Assay Kit (MAK085) from Sigma–Aldrich (USA). C. albicans and
C. krusei cultures (106 CFU) were incubated with TesTI at the
MIC in 0.15 M NaCl for 24 h at 37◦C. The cells were disrupted
using a lysis buffer (300 µL) containing 3 µL of butylated
hydroxytoluene (100×) and the samples were centrifuged at
13,000× g for 10 min. The supernatants (200 µL) were collected
in microcentrifuge tubes and 600 µL of thiobarbituric acid
(TBA) was added to each tube. The assays were incubated for
60 min at 95◦C and then in an ice bath for 10 min. The
absorbance was read at 532 nm using a spectrophotometer.
Reactions performed in absence of cell lysates were used as
blanks. The concentration of malondialdehyde (end product of
lipid peroxidation) was determined using a standard curve (0–
20 nmol). Three independent experiments were performed in
triplicate.
Cytotoxicity Assay
Peripheral blood mononuclear cells were obtained from
heparinized blood from healthy and non-smoking donors
(n = 3) who had not taken any drugs for at least 15 days
before the sample collection. The PBMCs were isolated using
a standard method of density-gradient centrifugation over
Ficoll-Hypaque (GE Healthcare Life Sciences, Sweden). Cells
were counted in a Neubauer chamber and viability was
determined by the trypan blue exclusion method. Cells were
only used in the assays when viability was higher than 98%.
All donors signed an informed consent form and the study
was approved by the Human Research Ethics Committee of
the Universidade Federal de Pernambuco (CEP/CCS/UFPE N◦
145/09).
In each assay, the PBMCs (1 × 106 cells/mL) were plated in
96-well microtiter plates and, after 24 h, TesTI (in 0.15 M NaCl)
was added to different wells in order to obtain the concentrations
10 and 100 µg/mL. After incubation (48 h at 37◦C), 100 µL of
a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) solution (5.0 mg/mL) was added to each well, and the
cell viability was determined by assessing the ability of the viable
cells to reduce the yellow tetrazolium to a blue formazan product.
After 3 h, the formazan was dissolved in 20% (w/v) sodium
dodecyl sulfate (SDS), and absorbance at 570 nm was measured
using a multi-plate reader (ELX 800, Biotek, USA). The effect
of TesTI was quantified as percentage of the absorbance of the
reduced dye in control (cells treated only with 0.15 M NaCl).
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The assays were performed in triplicate in two independent
experiments.
Statistical Analysis
Means and standard deviations (SD) were calculated and data
were expressed as a mean of replicates ± SD. Significance
between groups was determined by Student’s t-test or Tukey’s test
at significance level of p < 0.05.
RESULTS
The extract from T. stans leaves showed protein concentration
of 23.52 mg/mL and trypsin inhibitor activity of 93.0 U/mg.
In order to promote a partial purification of the proteins, the
extract was submitted to treatment with ammonium sulfate.
The precipitate fraction obtained showed higher specific trypsin
inhibitor activity (1,540 U/mg). The supernatant fraction could
also reduce the activity of trypsin; however, its specific activity
(600 U/mg) was lower than that of the precipitate fraction. Then,
the precipitate fraction was chosen to continue the purification
process, being the starting point for the chromatographic
steps.
Initially, the precipitate fraction was submitted to
chromatography on DEAE-Cellulose column. As can be seen
in Figure 1A, three peaks of adsorbed proteins were detected.
The pool PII showed the highest specific trypsin inhibitor
activity (1,833 U/mg). Nevertheless, it was still quite pigmented
and showed several polypeptide bands with low resolution in
polyacrylamide gel electrophoresis (data not shown), indicating
the necessity of another chromatography step. This second step
consisted in a gel filtration chromatography, which separated
PII in three peaks (Figure 1B). The pool PIIa, corresponding to
molecules with mass ranging from 23.2 to 47.5 kDa, showed no
color and inhibited trypsin at 8421 U/mg. PIIb (molecules with
mass ranging from 4.7 to 23.1 kDa) was strongly colored and also
showed trypsin inhibitor activity (4794 U/mg). PIIc (molecules
TABLE 1 | Summary of purification of the trypsin inhibitor from Tecoma
stans leaves (TesTI).
Sample Protein
concentration
(mg/mL)
Specific inhibitor
activity (U/mg)
Purification
(fold)
Leaf extract 23.52 93 1.0
Precipitate fraction 1.8 1540 16.6
PII 0.137 1833 19.7
PIIa 0.067 8421 90.5
TesTI 0.046 22,400 240.8
Specific trypsin inhibitor activity corresponds to the ratio of trypsin inhibitor activity
(U) and the amount of protein (mg) in the sample in the assay. Precipitate fraction
obtained after treatment of leaf extract with ammonium sulfate (80% saturation).
PII: main protein peak eluted from the chromatography of precipitate fraction on
the ion exchange column DEAE-cellulose. PIIa: main protein peak obtained from
chromatography of PII on HiPrep 16/60 Sephacryl S-100 HR column. TesTI was
recovered after chromatography of PIIa on ion exchange column DEAE FF 16/10.
Purification factor corresponded to the ratio of the specific trypsin inhibitor activity
of each sample to that of the leaf extract.
with mass < 4 kDa) was highly pigmented and did not inhibit
trypsin.
Finally, a third chromatography step was performed by
submitting the pool PIIa to an ion exchange DEAE FF 16/10
column. In the elution step, performed using a 1.0 M NaCl
gradient (0–100%), three peaks were recovered (Figure 1C).
Only the peak corresponding to fractions eluted with 50–64%
of 1.0 M NaCl inhibited trypsin, and this was named TesTI
(T. stans trypsin inhibitor). Table 1 summarizes the process of
TesTI purification. Two-dimensional electrophoresis of TesTI
(Figure 2) yielded a single spot, with molecular weight of
39.8 kDa and pI of 3.41. TesTI showed a K i of 43 nM toward
bovine trypsin. Once confirmed the homogeneity of TesTI, we
started the evaluation of antifungal activity.
Antifungal activity was evaluated for the leaf extract,
precipitate fraction, and TesTI; the results are shown in
Table 2. Similar results were obtained in assays performed
with cultures containing only yeast form (30◦C) or both yeast
and hyphal forms (37◦C). The leaf extract did not show
antifungal activity, while the fraction inhibited the growth of all
species. TesTI was more effective than the fraction in inhibiting
the growth of C. albicans and C. krusei but was not active
against C. tropicalis. No fungicide activity was detected in the
fraction, while TesTI was cytotoxic to C. albicans and C. krusei
(Table 2).
The species that were sensitive to TesTI had their growth
curves at 37◦C established when incubated or not with the
inhibitor at the MIC. It is possible to note that the growth of
C. albicans was significantly (p< 0.05) different in regard to 100%
growth control from the sixth hour (Figure 3A) while that of
C. krusei was significantly (p < 0.05) reduced from the ninth
hour (Figure 3B). Figure 4A shows that ATP levels were not
significantly different (p > 0.05) in C. albicans cells and control
when incubated with TesTI at 1/2 MIC and 1/4 MIC; however, the
levels were significantly lower (p < 0.05) in cells treated with
TesTI at MIC. For C. krusei, the ATP levels were significantly
(p < 0.05) lower when treated at MIC, 1/2 MIC, and 1/4 MIC. As
expected, the ATP levels in C. albicans and C. krusei incubated at
MFC were negligible. At MIC, TesTI induced lipid peroxidation
in C. albicans and C. krusei since malondialdehyde content for
treated cells was higher than that of control cells (Figure 4B).
Based on the MIC values found in antifungal assay, we
determined the toxicity of TesTI to non-target cells. In the
cytotoxicity assays, the vehicle (0.15 M NaCl) did not alter the
viability of PBMCs and thus the results were used as the 100%
growth control. TesTI (10 and 100 µg/mL) was not cytotoxic
agent to normal PBMCs since there was no reduction in cell
viability in comparison with control (Figure 5).
DISCUSSION
The previous reports on antimicrobial properties of protease
inhibitors, the presence of trypsin inhibitor (a class of defense
proteins) in T. stans leaves and the emergence of Candida
strains resistant to currently available chemotherapeutic agents
prompted us to conduct this study. Given that the leaves of
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T. stans contain trypsin inhibitor, we undertook efforts in order
to isolate this protein and to evaluate whether it would have
potential for application as an antifungal agent. If this antifungal
potential was proven, our planning would follow with the
evaluation of action mechanisms and cytotoxicity to human cells.
The isolation of TesTI included an ammonium sulfate
fractionation and three chromatographic steps. The higher
specific trypsin inhibitor activity of precipitate fraction in
comparison with leaf extract and supernatant fraction indicates
that protein precipitation resulted in partial purification of
trypsin inhibitor molecules.
The results from chromatography of precipitate fraction on
DEAE-Cellulose column indicated that most of the proteins in
the fraction were anionic in nature, since they adsorbed to the
cationic matrix. The high pigmentation and the detection of
several polypeptide bands in electrophoresis lead us to perform
the other chromatographic steps described above. Since the
pool PIIa, from gel filtration chromatography, was colorless
and showed the highest specific activity, it was chosen for
the chromatography on DEAE FF 16/10 column, which finally
yielded a homogeneous protein preparation containing TesTI.
The isoelectric focusing confirmed TesTI as an anionic protein
as indicated since the first chromatography step.
Following the successful isolation of TesTI, we evaluated
its antifungal potential. The strains used were clinical isolates
obtained from ungula samples (C. albicans), oral cavity tumor
(C. tropicalis), and blood of a candidemia patient in ICU
(C. krusei). The results for leaf extract and precipitate fraction
FIGURE 2 | Two-dimensional electrophoresis of the trypsin inhibitor from leaves of T. stans (TesTI). A single spot, corresponding to a relative molecular
mass of 39.8 kDa and a pI of 3.41, was detected. The gel was stained with Coomassie Brilliant Blue.
TABLE 2 | Antifungal activity of leaf extract, precipitate fraction, and TesTI against Candida species.
Fungi Extract Precipitate fraction TesTI
Yeast
culture
Yeast/hyphae
culture
Yeast
culture
Yeast/hyphae
culture
Yeast
culture
Yeast/hyphae
culture
Candida albicans
MIC (µg/mL) ND ND 5,200 2,600 100 100
MFC (µg/mL) – – >5,200 >5,200 200 200
Candida krusei
MIC (µg/mL) ND ND 2,600 2,600 100 100
MFC (µg/mL) – – >5,200 >5,200 200 200
Candida tropicalis
MIC (µg/mL) ND ND 2,600 2,600 ND ND
MFC (µg/mL) – – >5,200 >5,200 – –
Antifungal assays were performed at 30◦C (using yeast cultures) or 37◦C (using yeast/hyphae cultures). MIC (minimal inhibitory concentration) and MFC (minimal fungicide
concentration) are expressed as protein concentration. Precipitate fraction obtained after treatment of leaf extract with ammonium sulfate (80% saturation). ND, not
detected. –, not evaluated, since inhibitory activity was not observed.
Frontiers in Microbiology | www.frontiersin.org 6 April 2016 | Volume 7 | Article 611
fmicb-07-00611 April 25, 2016 Time: 11:48 # 7
Patriota et al. Antifungal Protein from Tecoma stans Leaves
FIGURE 3 | Growth curves of Candida albicans (A) and Candida krusei (B) in absence and presence of TesTI at MIC. The absorbance (600 nm) was
determined every hour during 24 h. Negative control contained only culture medium and did not receive microbial culture. The 100% growth control contained a 1:1
dilution of culture medium in water. Data are expressed as the mean ± standard deviation (SD).
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FIGURE 4 | ATP and lipid peroxidation levels of untreated and TesTI-treated C. albicans and C. krusei cells. (A) ATP levels in TesTI-treated cells at MFC,
MIC, 1/2 MIC, and 1/4 MIC. The relative ATP levels were calculated by the ratio between the value in the test assay and that in the control assay (which was
considered 1.0). (B) Malondialdehyde (MDA) levels from cells of control and TesTI-treated at MIC. Different letters indicate significant differences between treatments.
Lowercase letters were used for comparison of C. albicans results and uppercase letters for C. tropicalis.
FIGURE 5 | Viability of human peripheral blood mononuclear cells
(PBMCs) incubated with TesTI (10 and 100 µg/mL). Results are
expressed as percentage of viability in comparison with control using 0.15 M
NaCl (100% viability).
show that salt fractionation was effective in concentrating
antifungal agents that were diluted in the extract. The results
obtained with TesTI reveal an interesting specificity of the
inhibitor, particularly with respect to the different effects
on C. albicans and C. tropicalis, which are closely related
taxonomically (Chai et al., 2010). The fact that TesTI was not
active against C. tropicalis indicates that the T. stans leaves
contain other antifungal agents than the trypsin inhibitor isolated
in this work.
The other assays were then performed using the yeast/hyphae
cultures since the results from assays performed at 30 and 37◦C
were similar and the hyphal form is closer to the situation
of the pathogen in human body. The time-response curve for
C. albicans indicates that TesTI not only disrupts the replication
of the cells at MIC but also promotes cell death since the optical
density at 24 h was lower than that in the start of the experiment.
In addition, the curves indicate that TesTI was more effective on
C. albicans than C. krusei.
Incubation of fungal cells with TesTI at MIC and MFC
resulted in decreasing of the ATP content for both Candida
strains, which may be due to a lower number of viable cells. In
the treatments at the MIC, the ATP level was much lower for
C. albicans than that for C. krusei, which is in accordance with the
result of the growth curves, which also indicated a lower viability
of C. albicans. With respect to treatments with concentrations
below, it was detected ATP levels significantly (p < 0.05) lower
than in the control only for C. krusei. This may be linked to
an initial disruption of energy metabolism, since ATP levels
decreased even at sub-inhibitory concentrations. ATP depletion
is usually associated with damage to mitochondria caused by
oxidative stress (Al-Dalaen and Al-Qtaitat, 2014), initiated by
alterations in the redox balance in biological systems due to
predominance of pro-oxidant species (usually ROS). Most of the
cellular components (proteins, carbohydrates, lipids, and DNA)
are potential targets of ROS, which cause loss of function and
induce cell death. Since our assays revealed a decrease in ATP
levels at inhibitory and sub-inhibitory concentrations of TesTI,
we investigated whether the inhibitor induced oxidative stress
in Candida cells by determining the levels of lipid peroxidation.
Indeed, lipid peroxidation was detected.
The lipid peroxidation may occur through direct action of
the ROS or by a secondary mechanism involving the products
of lipid peroxidation. At the membrane, lipid peroxidation
propagates the formation of new peroxyl radicals, which
destabilize the membrane and affect the function of receptors,
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signal transducers, transport proteins and enzymes (Halliwell
and Gutteridge, 2007). Macedo et al. (2016) showed that the
trypsin inhibitor from I. laurina seeds induced the production
of ROS in C. tropicalis and C. buinensis cells after incubation
for 24 h and the authors suggested that the inhibitor could have
a mitochondrial target. Our study with TesTI is another report
on the induction of oxidative stress by a proteinaceous trypsin
inhibitor.
Other peptides have induced oxidative stress in Candida
cells. The antimicrobial peptide pleurocidin (from Pleuronectes
americanus skin mucous) induced the production of intracellular
ROS in C. albicans, which resulted in DNA fragmentation and
mitochondrial membrane depolarization (Cho and Lee, 2011).
A peptide from Heuchera sanguinea seeds exerted antifungal
activity by interfering with mitochondrial functionality, causing
accumulation of ROS in cells of Saccharomyces cerevisiae and
C. albicans (Aerts et al., 2011).
Since compounds with high toxicity against human cells
would not be viable for use as antifungal agents, we evaluated the
toxicity of TesTI to human PBMCs. The inhibitor did not show
any toxicity at concentrations of 10 and 100 µg/mL, indicating
that it can be considered as a potential drug to control Candida
infections.
CONCLUSION
The TesTI is an anionic protein with no toxicity to human
PBMCs and that promotes oxidative stress in C. albicans
and C. krusei, which probably impairs energy metabolism.
A decrease in the availability of ATP for use in metabolic
reactions probably affected morphogenesis and division
of Candida cells, resulting in growth inhibition and cell
death.
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